These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 18625454)

  • 1. Therapeutics for Alzheimer's disease based on the metal hypothesis.
    Bush AI; Tanzi RE
    Neurotherapeutics; 2008 Jul; 5(3):421-32. PubMed ID: 18625454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug development based on the metals hypothesis of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2008 Oct; 15(2):223-40. PubMed ID: 18953111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
    Summers KL; Roseman G; Schilling KM; Dolgova NV; Pushie MJ; Sokaras D; Kroll T; Harris HH; Millhauser GL; Pickering IJ; George GN
    Inorg Chem; 2022 Sep; 61(37):14626-14640. PubMed ID: 36073854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
    Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
    J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal complexing agents as therapies for Alzheimer's disease.
    Bush AI
    Neurobiol Aging; 2002; 23(6):1031-8. PubMed ID: 12470799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease & metals: therapeutic opportunities.
    Kenche VB; Barnham KJ
    Br J Pharmacol; 2011 May; 163(2):211-9. PubMed ID: 21232050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper in the brain and Alzheimer's disease.
    Hung YH; Bush AI; Cherny RA
    J Biol Inorg Chem; 2010 Jan; 15(1):61-76. PubMed ID: 19862561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metals and amyloid-beta in Alzheimer's disease.
    Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
    Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta metal interaction and metal chelation.
    Cuajungco MP; Frederickson CJ; Bush AI
    Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metallobiology of Alzheimer's disease.
    Bush AI
    Trends Neurosci; 2003 Apr; 26(4):207-14. PubMed ID: 12689772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
    Lannfelt L; Blennow K; Zetterberg H; Batsman S; Ames D; Harrison J; Masters CL; Targum S; Bush AI; Murdoch R; Wilson J; Ritchie CW;
    Lancet Neurol; 2008 Sep; 7(9):779-86. PubMed ID: 18672400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
    Ryan TM; Roberts BR; McColl G; Hare DJ; Doble PA; Li QX; Lind M; Roberts AM; Mertens HD; Kirby N; Pham CL; Hinds MG; Adlard PA; Barnham KJ; Curtain CC; Masters CL
    J Neurosci; 2015 Feb; 35(7):2871-84. PubMed ID: 25698727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity.
    Crouch PJ; Savva MS; Hung LW; Donnelly PS; Mot AI; Parker SJ; Greenough MA; Volitakis I; Adlard PA; Cherny RA; Masters CL; Bush AI; Barnham KJ; White AR
    J Neurochem; 2011 Oct; 119(1):220-30. PubMed ID: 21797865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition metal chelator therapy--a potential treatment for Alzheimer's disease?
    Gnjec A; Fonte JA; Atwood C; Martins RN
    Front Biosci; 2002 Apr; 7():d1016-23. PubMed ID: 11897554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual histology of Alzheimer's disease: Biometal entrapment within amyloid-β plaques allows for detection via X-ray phase-contrast imaging.
    Chourrout M; Sandt C; Weitkamp T; Dučić T; Meyronet D; Baron T; Klohs J; Rama N; Boutin H; Singh S; Olivier C; Wiart M; Brun E; Bohic S; Chauveau F
    Acta Biomater; 2023 Oct; 170():260-272. PubMed ID: 37574159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
    Rana M; Sharma AK
    Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and the amyloid beta peptide in Alzheimer's disease.
    Cheignon C; Tomas M; Bonnefont-Rousselot D; Faller P; Hureau C; Collin F
    Redox Biol; 2018 Apr; 14():450-464. PubMed ID: 29080524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metals in Alzheimer's and Parkinson's diseases.
    Barnham KJ; Bush AI
    Curr Opin Chem Biol; 2008 Apr; 12(2):222-8. PubMed ID: 18342639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.